Government's Endorsement of Caldicott2 is a Landmark Milestone for Patient Privacy

FairWarningFairWarning Inc., the inventor and global leader in patient privacy monitoring, has welcomed the UK government's response to the Caldicott Review, describing its decision to accept all of the recommendations in the review as "a significant step towards transparent care and a landmark milestone for both patients and the NHS."

But the company says the announcement, which coincides with the publication of the Health & Social Care Information Centre's (HSCIC) guide to confidentiality in health and social care, is just the latest step in the long journey towards electronic healthcare - and has urged healthcare stakeholders to work collaboratively to drive a culture of privacy throughout the NHS and ensure that the Caldicott2 recommendations are fully implemented within 12 months.

The Caldicott report was first published in April 2013, following an independent review into how information about individuals is shared across the health and social care system. FairWarningwas highly supportive of the original recommendations and is therefore extremely encouraged by the government’s decision to endorse all of the review's proposals.

FairWarning shares the government's view that effective information sharing will not only lead to better health outcomes, but it will also improve care pathways and enhance the patient experience. The company wholly supports the finding that there is no contradiction between increasing data sharing for care and improving the safeguards for personal confidential data.

However, electronic healthcare can only succeed if patients feel in greater control of their personal confidential information and are confident that the NHS is ensuring that information is secure, protected and shared appropriately. As such, moves to harness the power of information must be underpinned by robust information governance and information risk management processes that protect patient confidentiality.

Tim Dunn, General Manager for FairWarning UK commented: "Tools to help NHS professionals provide transparency on who is accessing patient records, and enabling trusts to monitor access proactively, are readily available and being successfully deployed in parts of the UK. We welcome that, in its response to Calidicott2, the government has acknowledged the implementation of privacy breach monitoring in Scotland. We believe that the full implementation of these recommendations could bring the rest of the UK to the high standard levels achieved in NHS Scotland, and ensure information assurance for UK trusts."

FairWarning considers the government's guidelines an important framework to ensure transparency and accountability for patient privacy. However, the company also believes the NHS' ability to implement the recommendations will be pivotal to the expansion of trust in digital healthcare.

Tim Dunn concluded: "It is now critical that Dame Fiona’s recommendations are implemented in a timely fashion, in line with the deadlines set out in the Caldicott Review and the response of the Department of Health (DH). Jeremy Hunt’s ambitions for electronic healthcare rely on executing this plan and protecting patient privacy will be at the heart of those efforts.

"The development of electronic healthcare models will indeed require both a step change and a concerted effort at national and local level. The time to act is now and FairWarning looks forward to supporting the DH and its partners in achieving these important goals."

About Caldicott2
The independent Information Governance Review led by Dame Fiona Caldicott, entitled 'Information: to share or not to share?' and also known as Caldicott2, was set up in February 2012 and delivered its final report and recommendations in April 2013. The aim of the review was to advise on how to achieve a better balance between protecting and sharing confidential personal information. The review produced a set of 7 revised "Caldicott Principles" and 26 specific recommendations. Dame Fiona will now chair an independent panel to oversee and scrutinise implementation of the review's recommendations and to provide advice on information governance issues.

About FairWarning, Inc.
FairWarning empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex privacy laws. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, and Canadian provincial healthcare privacy law.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...